Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FKEJK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,532
Award facts
- Contract value 100% obligated
- $7,531.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 266 mg/20 mL vials. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, does not utilize a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $500 million and extending through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capacity to fulfill diverse pharmaceutical product requirements across various therapeutic categories. This delivery order for EXPAREL, a local anesthetic used in surgical and pain management applications, aligns with the company's core business of providing specialized pharmaceutical products to support Department of Defense healthcare operations and medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FKEJK?
SPE2DB25FKEJK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FKEJK worth?
The government has obligated $7,532 on SPE2DB25FKEJK.
Is contract SPE2DB25FKEJK an order under another contract?
Yes. SPE2DB25FKEJK is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEJK competed?
The extent of competition for SPE2DB25FKEJK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award